Cipla Ltd, and its wholly owned subsidiaries, Cipla (EU) Limited, and Meditab Holdings Limited, have signed a Share Purchase Agreement with Africa Capitalworks SSA 3 for the sale of a 51.18% stake in Cipla Quality...
Pfizer will spend $43 billion to acquire Seagen
Pfizer will spend $43 billion to buy Seagen and deepen its reach into treating cancer. The pharmaceutical giant said Monday that it will pay $229 per Seagen share. “Together, Pfizer and Seagen seek to accelerate...
Sun Pharma completes acquisition of Concert Pharmaceuticals
Drug major Sun Pharma said it has completed the acquisition of US-based Concert Pharmaceuticals. In January, the Mumbai-based company inked a pact to acquire Concert in a USD 576 million deal. The drug major has...
Pfizer in talks to buy Seagen for likely for more than $30 bln – WSJ
Pfizer Inc is in early talks to acquire drugmaker Seagen Inc, the Wall Street Journal reported late on Sunday, citing people familiar with the matter. Seagen has a market value of some $30 billion and would be expected...
Sun Pharma acquires 26.09% stake in Agatsa Software, 27.39% in Remidio Innovative Solutions
Drug major Sun Pharma has announced that it has acquired a 26.09% stake in Agatsa Software Private Limited, which is in an early-stage digital diagnostic devices company, for ₹30 crore in two tranches. The acquisition...
Biocon sells 9.96% stake in contract research firm Syngene via open market
Indian biopharma company Biocon sold a 9.96% stake in its unit and contract research firm Syngene International through open market sale, it said in an exchange filing. With the sale, the total promoter stake...
Sun Pharma buys Disperzyme, Phlogam brands from Aksigen Hospital Care
Indian drug major Sun Pharmaceutical Industries said it has bought anti-inflammatory brands Disperzyme, Disperzyme-CD, and Phlogam from Mumbai-based Aksigen Hospital Care for an undisclosed amount. All three brands are...
Slovenian company Krka eyeing promoter stake in Unichem
Slovenian pharmaceutical company Krka, d. d., Novo mesto is in discussions to acquire the promoter’s stake in Mumbai-based Unichem Laboratories, said two people aware of the development. Promoter Prakash Amrut Mody...
Advent pips Blackstone, set to buy Suven Pharma for Rs 6300 cr
Advent International is expected to sign a binding agreement to buy Suven Pharmaceuticals, a Hyderabad-based listed contract research and manufacturing services (CRAMS) company, as early as Monday morning, people...
JB Pharma acquires cardiac brand from Glenmark for Rs 314 crore
JB Pharma on Wednesday said it has acquired cardiac brand Razel (rosuvastatin) for India and Nepal region from Glenmark for Rs 314 crore in an all-cash deal. The acquisition will be funded through long-term debt and...
Biocon completes $3.34 billion acquisition of Viatris’s biosimilar business
Biocon Biologics, a subsidiary of Biocon, announced the completion of the acquisition of the $3.34 billion Viatris’ global biosimilars business. Biocon Biologics will now recognize the combined revenue and associated...
Gland Pharma acquires French CDMO Cenexi for €120 million
Gland Pharma said that its Singapore subsidiary Gland Pharma International PTE has entered into an agreement to acquire 100% of France-based contract development & manufacturing organisation (CDMO) Cenexi Group for...
